Your browser doesn't support javascript.
loading
Efficacy of treatment with chimeric monoclonal antibody (Infliximab) to tumor necrosis factor-alpha for Crohn's disease in Japan: evaluation by rapid turnover proteins, and radiologic and endoscopic findings.
Asakura, H; Yao, T; Matsui, T; Koganei, K; Fukushima, T; Takazoe, M; Hobara, R; Nakano, H; Okamura, S; Matsueda, K; Kashida, H; Makiyama, K; Hiwatashi, N; Kashiwagi, K; Hibi, T.
Affiliation
  • Asakura H; Third Department of Internal Medicine, Niigata University School of Medicine, Niigata, Japan. asakura@med.niigata-u.ac.jp
J Gastroenterol Hepatol ; 16(7): 763-9, 2001 Jul.
Article in En | MEDLINE | ID: mdl-11446884
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Agents / Crohn Disease / Tumor Necrosis Factor-alpha / Antibodies, Monoclonal Type of study: Clinical_trials / Diagnostic_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: J Gastroenterol Hepatol Year: 2001 Document type: Article
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Agents / Crohn Disease / Tumor Necrosis Factor-alpha / Antibodies, Monoclonal Type of study: Clinical_trials / Diagnostic_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: J Gastroenterol Hepatol Year: 2001 Document type: Article